首页> 美国卫生研究院文献>Human Gene Therapy Methods >A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate
【2h】

A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate

机译:一种可扩展且准确的量化粗裂解物中重组腺相关病毒载体基因组的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Increasing interest and application of recombinant adeno-associated viruses (rAAVs) in basic and clinical research have urged efforts to improve rAAV production quality and yield. Standard vector production workflows call for genome titration of purified vectors at the endpoint of production to assess yield. Unfortunately, quality control measures for preparations during mid-production steps and economical means to assess the fidelity of multiple batches of rAAV preparations are lacking. Here we describe a scalable and accurate method for the direct quantitative polymerase chain reaction (qPCR) titration of rAAV genomes in crude lysate. Lysate samples are pretreated with DNase I to remove vector and packaging plasmid DNAs, followed by proteinase K to release endonuclease-resistant packaged viral genomes and to proteolyze factors inherent to crude lysates that can impinge upon quantitative PCR efficiencies. We show that this method is precise, scalable, and applicable for vector genome titrations of both single-stranded and self-complementary AAV genomes irrespective of serotype differences—a major limitation for standard lysate transduction methods that indirectly screen for vector packaging efficiency. Our described method therefore represents a significant improvement to rAAV vector production in terms of alleviating time and cost burdens, in-process quality control assessment, batch/lot monitoring in large-scale preparations, and good manufacturing practices.
机译:在基础和临床研究中,重组腺相关病毒(rAAV)的兴趣和应用日益增长,这促使人们努力提高rAAV的生产质量和产量。标准载体生产工作流程要求在生产终点对纯化载体进行基因组滴定以评估产量。不幸的是,缺乏在中间生产步骤中的制剂的质量控制措施和评估多批次rAAV制剂的保真度的经济手段。在这里,我们描述了一种可扩展且准确的方法,用于在粗裂解物中直接定量rAAV基因组的定量聚合酶链反应(qPCR)滴定。裂解液样品用DNase I预处理,以去除载体和包装质粒DNA,然后用蛋白酶K释放抗内切核酸酶的包装病毒基因组,并水解可能影响定量PCR效率的粗制裂解液固有的因子。我们证明了这种方法是精确,可扩展的,并且适用于单链和自互补AAV基因组的载体基因组滴定,而与血清型差异无关-这是间接筛选载体包装效率的标准裂解物转导方法的主要局限。因此,我们所描述的方法在减轻时间和成本负担,过程中质量控制评估,大规模制备中的批次/批次监控以及良好的生产实践方面代表了rAAV载体生产的重大改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号